Dual contacts between peptide agonist ligands and the secretin receptor directly established by photoaffinity labeling

被引:0
作者
Dong, MQ [1 ]
Wang, Y [1 ]
Miller, LJ [1 ]
机构
[1] Mayo Clin, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA
来源
VIP, PACAP, GLUCAGON, AND RELATED PEPTIDES | 2000年 / 921卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Structural analysis of secretin in solution has demonstrated extended helical domains within both amino- and carboxyl-terminal halves, with a possible turn in between. However, the conformation of this peptide as it resides in its binding site within the receptor has not been established. In the work reported here, we performed affinity labeling of the secretin receptor with radioiodinated secretin analogues having photolabile benzoyl-phenylalanine residues positioned in each half of the peptide. The probes had sites of covalent attachment in positions 6 and 22, and have been recently synthesized and characterized to represent high affinity agonist ligands. Both covalently labeled the secretin receptor in a saturable, specific, and efficient manner. After purification of the labeled receptor, we used a series of chemical and enzymatic cleavage techniques to define the domain of labeling. We complemented this by receptor mutagenesis, followed by additional cleavage and Edman degradation sequencing to refine our insights into the labeled residues. This has allowed us to demonstrate that sites of attachment were both within the extracellular aminoterminal domain of the receptor. Of particular interest, both probes labeled residues within the amino-terminal thirty residues at the distal end of the receptor. It will be particularly interesting to use these molecular approximations to model the binding domain of this important receptor.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 50 条
[21]   Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling [J].
Dong, MQ ;
Liu, GM ;
Pinon, DI ;
Miller, LJ .
BIOCHEMISTRY, 2005, 44 (17) :6693-6700
[22]   Differential docking of high affinity peptide ligands to types A and B cholecystokinin receptors demonstrated by direct photoaffinity labeling [J].
Dong, M ;
Liu, G ;
Pinion, DI ;
Miller, LJ .
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 :430A-430A
[23]   Identification of peptide ligand-binding domains within the human motilin receptor using photoaffinity labeling [J].
Coulie, B ;
Matsuura, B ;
Dong, MQ ;
Hadac, EM ;
Pinon, DI ;
Feighner, SD ;
Howard, AD ;
Miller, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) :35518-35522
[24]   AGONIST-INDUCED ALTERATIONS IN LYMPHOCYTE BETA-ADRENERGIC-RECEPTOR PHOTOAFFINITY-LABELING - EFFECTS OF PHENYLARSINE OXIDE [J].
FELDMAN, RD ;
MCARDLE, W ;
LAI, C .
FEDERATION PROCEEDINGS, 1986, 45 (03) :322-322
[25]   Molecular approximations between residues 21 and 23 of secretin and its receptor: Development of a model for peptide docking with the amino terminus of the secretin receptor [J].
Dong, Maoqing ;
Lam, Polo C. -H. ;
Gao, Fan ;
Hosohata, Keiko ;
Pinon, Delia I. ;
Sexton, Patrick M. ;
Abagyan, Ruben ;
Miller, Laurence J. .
MOLECULAR PHARMACOLOGY, 2007, 72 (02) :280-290
[26]   Photoaffinity labeling demonstrates physical contact between vasoactive intestinal peptide and the N-terminal ectodomain of the human VPAC1 receptor [J].
Tan, YV ;
Couvineau, A ;
Van Rampelbergh, J ;
Laburthe, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) :36531-36536
[27]   Direct demonstration of unique mode of natural peptide binding to the type 2 cholecystokinin receptor using photoaffinity labeling [J].
Dong, Maoqing ;
Miller, Laurence J. .
PEPTIDES, 2013, 46 :143-149
[28]   COMPARISON OF MAMMALIAN ALPHA-1-ADRENERGIC RECEPTOR PEPTIDES BY PHOTOAFFINITY-LABELING AND PEPTIDE-MAPPING [J].
LEEBLUNDBERG, LMF ;
DICKINSON, KEJ ;
WIKBERG, JES ;
STILES, GL ;
LEFKOWITZ, RJ ;
CARON, MG .
FEDERATION PROCEEDINGS, 1984, 43 (04) :834-834
[29]   CHARACTERIZATION AND PHOTOAFFINITY-LABELING OF A CALCITONIN GENE-RELATED PEPTIDE RECEPTOR SOLUBILIZED FROM HUMAN CEREBELLUM [J].
STANGL, D ;
BORN, W ;
FISCHER, JA .
BIOCHEMISTRY, 1991, 30 (35) :8605-8611
[30]   μ Opioid receptor mutations confer agonist activity to non-peptide ligands and zinc [J].
Mathes, WF ;
Ren, Y ;
McBride, EW ;
Beinborn, M ;
Kopin, AS .
FASEB JOURNAL, 2001, 15 (05) :A897-A897